Clinical Trial Update: A Platform Study of In Vivo CAR-T for Treating Advanced Malignant Tumors Based on Target Screening [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 platform trial evaluating in vivo CAR-T therapy for advanced malignant tumours based on target screening is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• In vivo CAR-T platform (In vivo CAR-T therapy)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Advanced Malignant Tumours | EARLY_Phase 1 | Status: RECRUITING